Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 22, 2019 - Teva Pharmaceuticals launched an AB-rated generic version of Novartis’ Exjade (deferasirox) tablets for oral suspension.
Download PDF
Return to publications
